Alkynyl nicotinamides show antileukemic activity in drug-resistant acute myeloid leukemia
Ontology highlight
ABSTRACT: We identified novel nicotinamide-based FLT3 inhibitors ( HSN748) that specifically target FLT3-ITD at sub-nanomolar concentrations and are effective against drug-resistant secondary mutations. In the current study, we evaluated these compounds’ antileukemic activity against FLT3-ITD and gatekeeper mutations in drug-resistant AML, relapsed/refractory AMLs with FLT3 mutations
ORGANISM(S): Homo sapiens
PROVIDER: GSE221459 | GEO | 2024/06/15
REPOSITORIES: GEO
ACCESS DATA